It is not widely known that medications currently are available to treat alcohol dependence and which have similar effectiveness to modern antidepressants (Bouza et al. 2005; Johnson 2007; Mann et al. 2004). Naltrexone and topiramate both reduce relapse in early abstinence patients by 20 to 30 percent, resulting in more people attaining sustained periods of abstinence compared with people taking placebo (Bouza et al. 2005; Johnson 2007; Johnson et al. 2003; Mann et al. 2004). A much older drug, disulfiram, is effective if used properly to ensure adherence (O’Farrell et al. 1995), and it has the advantage of being very inexpensive. Several other medications have some evidence of effectiveness and many more are in various stages of development (Johnson 2007; Srisurapanont and Jarusuraisin 2005). These medications are ideal for treating large numbers of people with functional AUDs in a discrete, familiar setting, such as the family doctor’s office. Coupled with brief support directed at encouraging medication adherence, attendance at community support groups, and abstinence, these medications are as effective as state-of-the-art behavioral treatment, at least among people seeking help for their drinking. Recovery 2-Day (R2D) helps you treat each and interrupt cravings. Cravings happen when a person tries to quit using alcohol or drugs. R2D can show you safe cognitive tools in less than thirty minutes that you can practice daily to help yourself get well. By using the BlogTalkRadio, R2D can keep you informed to the latest recovery news. Join us weekly and help spread the news, there is Recovery 2-Day and it starts now.
Sorry we couldn't complete your registration. Please try again.
Please enter your email to finish creating your account.
Receive a personalized list of podcasts based on your preferences.